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Abstract
Hierarchical models such as the bivariate and hierarchical summary receiver operating characteristic (HSROC) models
are recommended for meta-analysis of test accuracy studies. These models are challenging to fit when there are few
studies and/or sparse data (for example zero cells in contingency tables due to studies reporting 100% sensitivity or
specificity); the models may not converge, or give unreliable parameter estimates. Using simulation, we investigated the
performance of seven hierarchical models incorporating increasing simplifications in scenarios designed to replicate
realistic situations for meta-analysis of test accuracy studies. Performance of the models was assessed in terms of
estimability (percentage of meta-analyses that successfully converged and percentage where the between study
correlation was estimable), bias, mean square error and coverage of the 95% confidence intervals. Our results
indicate that simpler hierarchical models are valid in situations with few studies or sparse data. For synthesis of
sensitivity and specificity, univariate random effects logistic regression models are appropriate when a bivariate model
cannot be fitted. Alternatively, an HSROC model that assumes a symmetric SROC curve (by excluding the shape
parameter) can be used if the HSROC model is the chosen meta-analytic approach. In the absence of heterogeneity,
fixed effect equivalent of the models can be applied.
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1 Introduction
Meta-analysis of test accuracy studies aims to produce reliable evidence about the diagnostic accuracy of a medical
test from multiple studies addressing the same question. The bivariate model1 and the hierarchical summary
receiver operating characteristic (HSROC) model2 are the two approaches recommended for meta-analysis
when a sensitivity and speciﬁcity pair is available for each study.3–5 These hierarchical models possess
theoretical advantages over simpler methods for meta-analysis of test accuracy studies but ﬁtting them is not
trivial. The models are often ﬁtted using a frequentist approach that relies on likelihood based methods for the
estimation of ﬁve parameters. Solving the likelihood equations requires an iterative process and in certain
circumstances, for instance when there are few studies and/or sparse data (e.g. zero cells due to perfect
sensitivity and/or speciﬁcity) in a meta-analysis, the models fail to converge or they converge but give
unreliable parameter estimates with one or more missing standard errors. These issues are often encountered by
meta-analysts6 and there is uncertainty about how to proceed with meta-analysis in such situations.
Academic illustrations of the application of hierarchical methods have typically involved large meta-
analyses.1,2,4,7–13 In contrast, our experience of supporting Cochrane and non-Cochrane diagnostic test
accuracy review authors suggest that small meta-analyses or sparse data often occur and pose a challenge to
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these data hungry hierarchical models. Others have also noted the problem of non-convergence.8,10,14–16 Despite
the increasing uptake of these models, a recent survey has suggested a lack of clarity about recommended methods
for meta-analysis and a need for guidance.16 In this paper, using simulation, we evaluate the performance of
hierarchical models for meta-analysis of diagnostic accuracy studies, and we develop recommendations for their
use. Because sensitivity and speciﬁcity are the test accuracy measures most commonly used in meta-analyses,17 we
consider only methods for synthesis of these measures. Other measures such as likelihood ratios can be derived
from functions of the bivariate or HSROC model parameters.
The outline of this paper is as follows. In section 2 we brieﬂy describe common methods used for meta-analysis
when each study contributes a single 2 x 2 table of the results of an index test cross classiﬁed with a reference
standard. In section 3 we outline two motivating examples where the bivariate model failed to converge, and we
apply simpler forms of the hierarchical models to resolve this. In section 4 we describe the simulation study and
present the results for full and simpliﬁed hierarchical models. In section 5 we discuss our ﬁndings and conclude
with recommendations for selecting an appropriate meta-analytic approach in practice.
2 Methods for meta-analysis of diagnostic accuracy studies
2.1 Univariate pooling methods
Univariate ﬁxed eﬀect or random eﬀects meta-analytic methods pool sensitivity and speciﬁcity separately, ignoring
any correlation that may exist between the two measures. Fixed eﬀect models assume homogeneity while random
eﬀects models assume variability in test accuracy beyond sampling error alone by allowing each study to have its
own test accuracy, i.e. the model includes a between study variance component (2). Let Ai and Bi be the logit
sensitivity and logit speciﬁcity, and 2Ai and 
2
Bi their variances for the ith study (i¼ 1, 2, . . . ,N), then the models for
sensitivity and speciﬁcity are speciﬁed as
Ai  N A, 2A
 
, Bi  N B, 2B
  ð1Þ
The simplest and most commonly used random eﬀects method is the DerSimonian and Laird approach which uses
a normal distribution to model within study variability. Logit transformed sensitivity or speciﬁcity and the within
study variance are undeﬁned when there are zero cells. A continuity correction (typically 0.5) is applied, leading to
a downward bias in test accuracy.6 Therefore, univariate methods that use a binomial distribution to model within
study variability are preferred. However, these logistic models are seldom used in practice probably due to lack of
awareness of the methods or software limitations.
2.2 Summary receiver operating characteristic regression
The summary receiver operating characteristic (SROC) curve approach developed by Moses et al.18 accounts for
possible heterogeneity in threshold. It uses a logistic transformation of the true positive and false positive rates
(TPR and FPR) and linear regression to model the relationship between test accuracy and the proportion test
positive (related to threshold). If accuracy does not depend on threshold, the SROC curve is symmetric and can be
described by a constant diagnostic odds ratio (DOR). The DOR is a single measure of test accuracy deﬁned as the
ratio of the odds of positivity in those who have the target condition relative to the odds of positivity in those
without the condition. Therefore, a test with high TPR and low FPR will have a high DOR. This SROC approach
is a ﬁxed eﬀect method in which variation is attributed solely to threshold eﬀect and sampling error. The approach
has methodological limitations which lead to inaccurate standard errors, thus rendering formal statistical inference
invalid.10,13 Similar to the DerSimonian and Laird approach, zero cell corrections may be required.
2.3 Hierarchical models
Hierarchical models (also known as mixed or multilevel models) take into account correlation between sensitivity
and speciﬁcity across studies while also allowing for variation in test performance between studies through the
inclusion of random eﬀects. The two main approaches – the bivariate model and the HSROC model – diﬀer in
parameterizations, but the models are mathematically equivalent when no covariates are included.19 The choice of
approach is often determined by variation in the thresholds reported in the included studies and the focus of
inference – a summary point or a SROC curve.
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2.3.1 Bivariate random effects model
van Houwelingen et al.20 proposed a bivariate approach to meta-analysis that was adapted by Reitsma et al.1 for
test accuracy meta-analysis. This bivariate model is a linear mixed model that enables joint analysis of sensitivity
and speciﬁcity and takes the form
Ai
Bi
 
 N A
B
 
,
X
AB
 
with
X
AB
¼ 
2
A AB
AB 
2
B
 !
ð2Þ
The model assumes a bivariate normal distribution with mean A and variance 
2
A for the logit sensitivities, mean
B and variance 
2
B for the logit speciﬁcities and AB the covariance between Ai and Bi across studies. Instead of
the covariance, the model can be parameterized using the between study correlation, AB. Therefore, the bivariate
model without a covariate has the following ﬁve parameters: A, B, 
2
A, 
2
B and AB (or AB). Chu and
coworkers7,12 have shown that a binomial likelihood should be used for modelling within study variability
(especially when data are sparse) as follows:
yAi  Binomial nAi, g1 Aið Þ
 
, yBi  Binomial nBi, g1 Bið Þ
  ð3Þ
where yAi and yBi represent the number of true positives and true negatives, nAi and nBi the number of diseased and
non-diseased subjects and g1 Aið Þ and g1 Bið Þ the sensitivity and speciﬁcity in the ith study, respectively. The
logit link g :ð Þ is commonly used but other link functions can be applied.12,13 The random eﬀects also follow a
bivariate normal distribution in this generalized linear mixed model. If this bivariate model is simpliﬁed by
assuming the covariance or correlation is zero (i.e. an independent variance–covariance structure), the model
reduces to two univariate random eﬀects logistic regression models (UREMs) for sensitivity and speciﬁcity.
2.3.2 HSROC model
The Rutter and Gatsonis HSROC model represents a general framework for meta-analysis of test accuracy studies
and can be viewed as an extension of the Moses SROC approach in which the TPR and FPR for each study are
modelled directly.21 The HSROC model is a nonlinear generalized mixed model and takes the form
logit ij
  ¼ i þ idisij exp disij  ð4Þ
where ij is the proportion of test positives, true or false positives depending on disease status. Disease status is
represented by disij which is coded 0.5 for the non-diseased (j¼ 0) and 0.5 for the diseased group (j¼ 1) in the ith
study. The implicit threshold i (threshold parameter or positivity criteria) and diagnostic accuracy i (accuracy
parameter) for each study are modelled as random eﬀects with independent normal distributions i  N , 2
 
and i  N , 2
 
, respectively. The model also includes a shape or scale parameter  which enables asymmetry in
the SROC curve by allowing accuracy to vary with implicit threshold. Therefore, the SROC curve is symmetric if
 ¼ 0 or asymmetric if  6¼ 0. Each study contributes a single point in ROC space and so the estimation of 
requires information from all studies included in the meta-analysis. Thus  is modelled as a ﬁxed eﬀect. The
HSROC model has the following ﬁve parameters: , , , 2 and 
2
 . The model reduces to a ﬁxed eﬀect model if
2 ¼ 0 and 2 ¼ 0. Other speciﬁcations for SROC curves based on functions of the bivariate model have been
proposed10,22 but in this paper we focus only on the more established and commonly used Rutter and Gatsonis
model.
3 Motivating examples
3.1 Non-contrast computed tomography for diagnosing appendicitis
Hlibczuk et al.23 reviewed the diagnostic accuracy of non-contrast computed tomography (CT) for emergency
department evaluation of adults with suspected appendicitis. Seven studies, evaluating 1060 patients of whom 389
had appendicitis, were included in the review. The prevalence of appendicitis in the studies ranged from 20% to
84%, with a median of 39%. The forest plot (Figure 1) shows between study variation in the sensitivities and
speciﬁcities, though speciﬁcity was perfect (100%) in four studies. The authors attempted to ﬁt the bivariate model
in SAS but the model failed to converge.
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3.2 CT for diagnosing scaphoid fractures
Yin et al.24 assessed the diagnostic accuracy of CT for diagnosing suspected scaphoid fractures. Six studies,
evaluating 211 patients of whom 44 had a scaphoid fracture, were included in the review. The prevalence of
scaphoid fractures in the studies ranged from 12% to 38%, with a median of 20%. Figure 1 shows the estimates of
sensitivity and speciﬁcity with almost no between study variation; ﬁve of the six studies reported 100% sensitivity
while all studies reported 100% speciﬁcities. The authors pooled sensitivity, speciﬁcity and the DOR using a
random eﬀects model (method not speciﬁed).
3.3 Results from reanalysis of the two example datasets
We reanalyzed the two datasets by ﬁtting univariate, bivariate and HSROC models using the NLMIXED
procedure in the SAS software package (version 9.2; SAS Institute, Cary, NC). UREMs for sensitivity and
speciﬁcity were simultaneously obtained by setting the covariance parameter in a bivariate generalized linear
mixed model equal to zero. This is equivalent to assuming an independent variance–covariance structure.
Additional summary measures such as likelihood ratios and DORs were produced using the ESTIMATE
statement within NLMIXED. The ESTIMATE statement computes additional estimates as a function of
parameter values and produces standard errors and conﬁdence intervals (CIs) using the delta method. Despite
numerous attempts with diﬀerent starting values and optimization algorithms, the bivariate model failed to
converge for both datasets. In addition, the HSROC model containing all ﬁve parameters failed to converge
for the scaphoid fractures dataset. The models ﬁtted and results obtained for both datasets are summarised in
Table 1. For the appendicitis dataset, the complete HSROC model successfully converged and produced reliable
estimates only when boundary constraints (2 0) were speciﬁed for 2 and 2 ; the boundary constraint for 2
was activated (estimation truncated at zero) and the between study correlation was estimated as þ1. This is due to
the maximum likelihood estimator truncating the between-study covariance matrix on the boundary of its
parameter space.15 A bivariate model with a correlation of þ1 corresponds to an HSROC model with 2
truncated at zero, and a correlation of 1 corresponds to an HSROC model with 2 truncated at zero.
Since the maximum likelihood estimation problems encountered with the bivariate model are most likely due to
boundary estimation of the variance and/or covariance parameters, we attempted plotting the proﬁle log
likelihood for the covariance parameter (maximized with respect to the other 4 parameters). We were unable to
produce a plot for the scaphoid fracture example because the bivariate model failed even with ﬁxed values for the
covariance. This is unsurprising since there was almost no between study variation in sensitivity and speciﬁcity.
Figure 2 shows the proﬁle log likelihood for the covariance parameter for the appendicitis example. The
likelihood is ﬂat with very little change in the proﬁle log likelihood. The maximum of the proﬁle log likelihood
was achieved at a covariance of 0.02 (dashed line). For covariances above 0.02, the bivariate model failed to
converge or was unstable, but values between 0.05 and 0.02 appear to be supported by the data. The dotted line
Figure 1. Forest plot of sensitivity and specificity estimates from studies included in the two motivating examples. FN: false negative;
FP: false positive; TN: true negative; TP: true positive.
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shows the value of the log likelihood for a covariance of zero, i.e. independence between sensitivity and speciﬁcity.
This suggests that UREMs would be appropriate for pooling sensitivity and speciﬁcity in this example.
The two examples illustrate the problem of model convergence, poor parameter estimation and the need for
simpler models. There were only subtle diﬀerences in summary estimates and 95% CIs for sensitivity, speciﬁcity
and the negative likelihood ratio between models ﬁtted to the appendicitis dataset. In contrast, clear diﬀerences
were observed for the positive likelihood ratio and the DOR. For the scaphoid fractures dataset, there were
diﬀerences in summary estimates and 95% CI for sensitivity and speciﬁcity from the univariate ﬁxed eﬀect
model and the HSROC models with both ﬁxed accuracy and threshold parameters compared to the other
models. These examples show that results can diﬀer between models, and the diﬀerences may not be negligible.
Therefore, the identiﬁcation of simpler meta-analytic methods that give valid answers in situations where complex
models fail is of practical importance.
4 Simulation study
4.1 Simulation methods
We conducted a simulation study to compare the performance of a UREM and the HSROC model with various
simpliﬁcations (by removing model parameters). Given the mathematical equivalence of the HSROC and bivariate
models when no covariate is included, there was no need to examine the performance of both models. We chose the
HSROC model because it has greater ﬂexibility for introducing model parsimony by dropping parameters than the
bivariate model.19 Since several authors7–9,15 have shown that approximate methods for modelling within study
variability are biased, we only investigated methods that use a binomial likelihood. The speciﬁcations for the
scenarios were devised to replicate realistic situations encountered in meta-analysis of diagnostic accuracy studies.
We investigated the eﬀect of these factors: 1) number of studies; 2) magnitude of diagnostic accuracy (DOR); 3)
prevalence of disease; 4) between study variation in accuracy and threshold; and 5) asymmetry in the SROC curve.We
modiﬁed the simulation approach used in a previous study25 to deﬁne the simulation scenarios and generate the
simulated datasets as described below.
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Figure 2. Profile log-likelihood function of the covariance parameter in the bivariate model applied to the appendicitis example.
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4.1.1 Generation of simulated data
To determine diagnostic accuracy, we used the standardised distance between the means 1 and 2 (where
241) of the logistic distributions for non-diseased and diseased, respectively. We selected the diagnostic
threshold, t, as the average of the means of the two distributions, i.e. t ¼ 1 þ 2ð Þ=2. If the two distributions
have diﬀerent standard deviations (1 6¼ 2), sensitivity 6¼ speciﬁcity at t and the SROC curve has an asymmetric
shape. The DOR at t can be calculated as follows:
DOR ¼ exp
ﬃﬃﬃﬃﬃ
2
3
r
2  t
2
 1  t
1
 " #
ð5Þ
The sensitivity and speciﬁcity at t can be obtained using the following:
Sensitivity ¼
exp
ﬃﬃﬃﬃ
2
3
q
2t
2
 	 

1 exp
ﬃﬃﬃﬃ
2
3
q
2t
2
 	 
 ,
Specificity ¼ 1
exp
ﬃﬃﬃﬃ
2
3
q
1t
1
 	 

1þ exp
ﬃﬃﬃﬃ
2
3
q
1t
1
 	 

ð6Þ
When the distributions of test results for the diseased and non-diseased have the same standard deviation
(1 ¼ 2 ¼ ), sensitivity ¼ speciﬁcity at t and the SROC curve has a symmetric shape. For scenarios where
1 ¼ 2 ¼ , we investigated values of diagnostic accuracy that correspond to the following:
(1) 2  1ð Þ= ¼ 2 (log DOR¼ 3.63, DOR¼ 38; sensitivity¼ speciﬁcity¼ 0.86);
(2) 2  1ð Þ= ¼ 3 (log DOR¼ 5.44, DOR¼ 231; sensitivity¼ speciﬁcity¼ 0.94)
For scenarios where 2 ¼ 21, using the same 2 and 1 as in (1) and (2) above, the DOR of 38 reduces to 15
(sensitivity¼ 0.71 and speciﬁcity¼ 0.86) and the DOR of 231 reduces to 59 (sensitivity¼ 0.80 and
speciﬁcity¼ 0.94).
We investigated meta-analyses with diﬀerent number of studies (k¼ 5, 10, 20). The size of a study in each meta-
analysis, nj, was randomly sampled from a uniform distribution, U(20,200). We varied nj between 20 and 200
because diagnostic accuracy studies are often small in size.17,26 Given an underlying prevalence p, individuals
within each study were randomly classiﬁed as diseased or non-diseased, and assigned a continuous test result
value, x, which was randomly sampled from the logistic distributions. For each study, we used t to determine the
outcome of an individual’s test result; positive if xij4 t, or negative if xij  t. To create the 2 x 2 table for each
study, individuals were then classiﬁed as true positives, false negatives, false positives or true negatives based on
test result and disease status.
To begin we assumed zero between study variation in both accuracy and threshold. We then introduced
between study variation in diagnostic accuracy by adding a value 	 sampled from a normal distribution with
zero mean and standard deviation 0.31. This value was added to the diﬀerence in means (2  1) for each
study. We introduced between study variation in diagnostic threshold by also sampling from a normal
distribution with the average threshold t as the mean and standard deviation 0.31. We generated 10,000
independent meta-analysis datasets for each scenario to enable precise estimation of model performance even
if a large proportion of models fail to converge. If all 10,000 datasets for each scenario successfully converged,
they will give a standard error of 0.0022 for the estimation of 95% CI coverage probability.27 However if only
1000 datasets converged, the standard error will be 0.0069. The datasets were created using Stata version 10.1
(Stata-Corp, College Station, TX). Table 2 summarises the diﬀerent scenarios investigated. The meta-analysis
dataset for the base scenario for each DOR contained ﬁve studies with an underlying prevalence of 5% and
no heterogeneity in accuracy or threshold.
4.1.2 Meta-analytic models fitted to each dataset
Throughout the rest of this paper, we refer to an HSROC model that contained all ﬁve parameters as a complete
HSROC model. We ﬁtted the following seven models to each meta-analysis dataset.
1902 Statistical Methods in Medical Research 26(4)
(1) UREM – includes A and 
2
A for the logit sensitivities, and B and 
2
B for the logit speciﬁcities. Note this is a
simpliﬁcation of the bivariate generalized mixed model achieved by setting the covariance or correlation
parameter to zero (see section 2.3.1). For brevity, from here on we will refer to this model simply as the
univariate random eﬀects model.
(2) Complete HSROC model – includes all ﬁve parameters , , , 2 and 
2

(3) Symmetric HSROC model – includes , , 2 and 
2

(4) HSROC model with ﬁxed threshold – includes , ,  and 2
(5) HSROC model with ﬁxed accuracy – includes , ,  and 2
(6) HSROC model with ﬁxed accuracy and threshold – includes ,  and  (allows for asymmetry in the SROC
curve)
(7) Symmetric HSROC model with ﬁxed accuracy and threshold parameters – includes only two parameters 
and 
As shown by Harbord et al.,19 the ﬁve parameters of the bivariate model can be expressed in terms of those of the
HSROC model as follows:
A ¼ exp 
2
 
þ
2
 
, B ¼  exp 
2
 

2
 
ð7Þ
2A ¼ exp ð Þ 2 þ
1
4
2
 
, 2B ¼ exp ð Þ 2 þ
1
4
2
 
, AB ¼  2 
1
4
2
 
ð8Þ
For the ﬁxed accuracy threshold and symmetric ﬁxed accuracy threshold models, 2 ¼ 0 and 2 ¼ 0. Thus 2A ¼ 0,
2B ¼ 0 and AB ¼ 0, and both models are equivalent to simultaneously ﬁtting two univariate ﬁxed eﬀect logistic
regression models for sensitivity and speciﬁcity (see results for these models in Table 1). Henceforth, we refer to
them as ﬁxed eﬀect models; the models can be considered a special case of the random eﬀects models where the
variances of the random eﬀects are zero. We used the SAS NLMIXED procedure to ﬁt each of the seven meta-
analytic models because Stata does not have an inbuilt or user deﬁned command for ﬁtting non-linear generalized
mixed models. Note that because of the mathematical relationship between the bivariate and HSROC model, it is
possible in Stata to obtain estimates for the ﬁve parameters of the HSROC model using functions of parameters
from the bivariate model ﬁtted.19 We computed additional estimates by using the ESTIMATE statement. We
Table 2. Scenarios evaluated in the simulation.a
Scenario Prevalence (%) DOR
Heterogeneity in
accuracy and threshold
Asymmetry in
SROC curve
1–3 5 38 No No
4–6 25 38 No No
7–9 50 38 No No
10–12 5 38 Yes No
13–15 25 38 Yes No
16–18 50 38 Yes No
19–21 5 231 No No
22–24 25 231 No No
25–27 50 231 No No
28–30 5 231 Yes No
31–33 25 231 Yes No
34–36 50 231 Yes No
37–39 5 15 Yes Yes
40–42 25 15 Yes Yes
43–45 50 15 Yes Yes
46–48 5 59 Yes Yes
49–51 25 59 Yes Yes
52–54 50 59 Yes Yes
aEach subset of 3 scenarios corresponds to 5, 10 and 20 studies.
Takwoingi et al. 1903
computed the log DOR at the average operating point (summary sensitivity and speciﬁcity). This log DOR is
exactly the same value as  if the SROC curve is symmetric.
4.1.3 Facilitating convergence of hierarchical models
To aid convergence, we provided a wide range of starting values for model parameters by specifying a grid of
points for a grid search of starting values. We used a quasi-Newton optimization technique (the NLMIXED
default) because it provides an appropriate balance between computation speed and stability (SAS Institute Inc.
SAS OnlineDoc 9.1.3. Cary, NC, 2004). To prevent estimation of negative variances and to reduce computational
problems, we speciﬁed boundary constraints (2 0) for the variance parameters in the models. To reduce the
number of models that failed to converge, we reﬁtted models by trying a new set of starting values and/or changing
the optimization technique to a Newton-Raphson technique. To obtain a new set of starting values, we ﬁtted a
model with no random eﬀects and used the new parameter estimates together with the original grid of points for
the variance parameters. Thus for some datasets, we made up to four attempts to ﬁt a hierarchical model.
4.1.4 Assessment of model convergence and stability
Because a model that meets a convergence criterion may be unstable or have missing standard errors due to issues
with model identiﬁability, we assessed convergence in two stages. First, we checked whether the convergence
criterion was met and also whether the additional estimates deﬁned in the ESTIMATE statements were
produced. Second, because standard errors are computed from the ﬁnal Hessian matrix, we calculated
eigenvalues of the Hessian to detect if there were problems. At a true minimum, eigenvalues will all be positive,
i.e. positive deﬁnite. Therefore, for convergence to be deemed successful, the model had to meet the convergence
criterion, produce additional estimates, and the Hessian had to be positive deﬁnite.
4.1.5 Assessment of performance of meta-analytic models
We assessed performance of the methods by examining estimates of the following measures of diagnostic
accuracy: log DOR, logit sensitivity and logit speciﬁcity. We assessed estimability as the percentage of meta-
analyses that successfully converged and the percentage where the between study correlation was not estimated
as 1 or þ1. We computed the latter for only the complete HSROC model. For each scenario, we used only the
results from meta-analyses that successfully converged as deﬁned above to calculate (a) the diﬀerence between
the average parameter estimate and the true parameter value to determine bias; (b) the average standard error
and mean square error (MSE incorporates both bias and variability) to assess model accuracy; and (c) the
coverage of the 95% CIs by computing the percentage of meta-analyses for which the true parameter value was
within the 95% CI.
4.2 Simulation results
Altogether we explored 54 scenarios. We can only show results for the log DOR in this article but results for logit
sensitivity and logit speciﬁcity are brieﬂy mentioned. Because homogeneous accuracy and threshold are the
exception rather than the norm for meta-analysis of test accuracy studies, to illustrate key ﬁndings, we present
results mainly for scenarios with heterogeneity at a DOR of 231 (sparse data are of interest and zero false positives
and/or false negatives are more likely to occur when diagnostic accuracy is high).
4.2.1 Estimability
Zero cells occurred frequently especially when diagnostic accuracy was high (Table 3). Convergence rates were
higher for the complete HSROC model in scenarios with heterogeneity compared to scenarios without
heterogeneity. This is likely due to the inclusion of heterogeneity parameters in the HSROC model that become
problematic to estimate when the true heterogeneity is zero. Convergence increased with increasing number of
studies and prevalence, and with decreasing diagnostic accuracy. Convergence decreased in scenarios with
asymmetry in the SROC curve (data not shown). Across scenarios, non-convergence and problems with model
identiﬁability were more common with the complete HSROC and ﬁxed threshold models compared to the other
hierarchical models (Table 4); the symmetric ﬁxed accuracy threshold model always converged. The complete
HSROC model often poorly estimated the correlation between the logit transformed sensitivities and speciﬁcities
as þ1 or 1 (Table 3); estimation as 1 occurred much more frequently than þ1. The correlation was more likely
to be estimated between 1 and þ1 when there was heterogeneity in accuracy and threshold, greater prevalence of
disease and more studies in a meta-analysis.
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4.2.2 Bias
In the base scenario for a DOR of 231, the symmetric HSROC model gave the least percentage bias for the DOR
(4.32%); bias was highest for the ﬁxed threshold (37.8%) and ﬁxed accuracy (36.2%) models (Table 4). These
rankings were consistent as the number of studies increased. As prevalence increased, the two ﬁxed eﬀect models
became the least biased while the ﬁxed accuracy model remained the most biased.
When heterogeneity was introduced, each of the seven models produced the largest bias for the DOR at the
lowest prevalence, though the univariate random eﬀects model gave the least biased DOR. For all models, bias
decreased as prevalence and the number of studies increased. However, the decrease in bias resulted in a change
from overestimation to underestimation for the two ﬁxed eﬀect models. For bias in the estimates of sensitivity, we
observed results similar to those of the DOR, but the relationship with prevalence was reversed for bias in the
estimates of speciﬁcity (data not shown). Bias in speciﬁcity was very small compared to that of the DOR or
sensitivity. For the three measures, in scenarios with heterogeneity and asymmetry in the SROC curve, bias was
lower than in the corresponding symmetric model.
4.2.3 Model accuracy
A MSE of zero indicates that the model estimated the parameter of interest with perfect accuracy, i.e. no bias
and no variability in the estimation. The MSE of the DOR was highest for the symmetric ﬁxed
accuracy threshold model (40.7) but lowest for the symmetric HSROC model (4.26) in the base scenario
(Table 4). At higher prevalence, the two ﬁxed eﬀect models had the lowest MSE. For all models, the MSE
of the DOR decreased as the number of studies and prevalence increased. When heterogeneity was introduced,
the univariate random eﬀects model had the lowest MSE at 5% prevalence but the symmetric HSROC model
had slightly lower MSE than the univariate random eﬀects model at higher values of prevalence. As the number
of studies and prevalence increased, the MSE for all models decreased and became almost identical except for
those of the two ﬁxed eﬀect models. Results for sensitivity were similar to those for the DOR. The MSE for
speciﬁcity was generally very low and increased slightly with increasing prevalence. For the asymmetric SROC
curve scenarios, the ﬁndings for the three measures were similar to those of the corresponding symmetric
scenarios.
Table 3. Convergence and estimability of the complete HSROC model applied to 10,000 datasets in 36 different scenarios.a
DOR N
Prevalence
(%)
No heterogeneity in accuracy and threshold Heterogeneity in accuracy and threshold
Meta-
analyses
with a zero
cellb (%)
Successful
model fit
(positive
definite) (%)
% ^AB
¼1
% ^AB
¼þ1
% ^AB
6¼1 or
þ1
Meta-
analyses
with a zero
cellb (%)
Successful
model fit
(positive
definite) (%)
% ^AB
¼1
% ^AB
¼þ1
% ^AB
6¼1 or
þ1
38 5 5 48 18 14 2.6 1.8 50 36 21 0.6 14
38 5 25 50 18 15 1.7 1.6 51 54 31 0.2 22
38 5 50 52 18 15 1.4 2.0 53 60 34 0.2 26
38 10 5 60 25 17 3.7 4.4 60 52 21 0.2 31
38 10 25 65 24 18 2.4 3.8 67 77 24 0.0 54
38 10 50 72 25 18 2.6 4.1 73 85 24 0.0 61
38 20 5 75 32 20 5.8 6.4 77 70 20 0.0 50
38 20 25 77 30 20 3.7 6.3 78 93 12 0.0 82
38 20 50 82 28 20 3.1 5.8 84 97 10 0.0 88
231 5 5 96 18 11 5.7 1.4 97 30 18 2.4 10
231 5 25 97 21 14 5.0 1.6 98 43 29 2.1 13
231 5 50 99 21 15 4.7 1.9 99 48 31 2.3 14
231 10 5 99 23 13 7.7 3.0 99 41 21 1.3 19
231 10 25 99 29 17 7.6 4.1 100 62 29 0.9 33
231 10 50 100 29 18 6.7 4.1 100 71 32 0.9 39
231 20 5 100 29 15 9.7 4.8 100 54 20 0.3 34
231 20 25 100 35 20 9.2 6.2 100 80 23 0.2 57
231 20 50 100 35 20 9.2 6.5 100 88 22 0.1 66
^AB: estimated between study correlation; DOR: diagnostic odds ratio; N: number of studies.
aAll results are presented as percentages and are based on 10,000 meta-analysis datasets.
bThe percentage of meta-analyses out of 10,000 where at least one study included a zero cell.
Takwoingi et al. 1905
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4.2.4 Coverage
For a DOR of 231, the symmetric HSROC models gave the best coverage of the 95% CIs for estimation of the
DOR (95.5%) in the base scenario. With the exception of the symmetric ﬁxed accuracy threshold model, all models
were conservative as shown by coverage greater than 95%. The coverage of 88% for the symmetric ﬁxed accuracy
threshold model implied over-conﬁdence in the estimates but coverage increased as prevalence or the number of
studies increased. In contrast, introduction of heterogeneity led to very poor coverage for the two ﬁxed eﬀect
models with coverage becoming lower as prevalence increased. The univariate random eﬀects model and
symmetric HSROC model often showed good coverage, although the latter tended to show under-coverage as
prevalence increased. For sensitivity, the results were comparable to those of the DOR. Across all models,
coverage was low for speciﬁcity when there was heterogeneity unlike scenarios without heterogeneity. The
asymmetric SROC curve scenarios produced similar results to the symmetric SROC curve scenarios.
4.2.5 Summary of simulation results and application to motivating examples
The following key points were observed:
. Hierarchical models are more likely to converge if there is heterogeneity in accuracy and threshold.
. Convergence is also aﬀected by number of studies, prevalence and magnitude of diagnostic accuracy.
. Correlation between sensitivity and speciﬁcity across studies is often poorly estimated as þ1 or 1.
. In the absence of heterogeneity, the two ﬁxed eﬀect models were the least biased with low MSE and good
coverage properties for studies with moderate to high prevalence. The symmetric ﬁxed accuracy threshold
model may be of greater utility because it always converged. The symmetric HSROC model performed
better than both ﬁxed eﬀect models when prevalence was low and there were few studies, but this ﬁnding
was based on a convergence rate as low as 13%.
. When heterogeneity was present, the univariate random eﬀects model and the symmetric HSROC model were
often the least biased with low MSE and good coverage (however, there is a risk of selection bias in these results
for scenarios with lower prevalence with smaller numbers of studies where as few as 34% of simulations
converged).
In the simulation, the ﬁxed threshold model often gave biased and imprecise results. However, for the appendicitis
example, the ﬁxed threshold model gave results similar to the complete HSROC model. The results can be
explained by the fact that the estimation of 2 was truncated at zero in the complete model and so removing
2 from the HSROC model was appropriate in this example unlike in the simulation scenarios. The results in
Table 1 indicate that while the univariate random eﬀects model and symmetric HSROC model appear to be
generally applicable when there is heterogeneity, other models like the ﬁxed threshold or ﬁxed accuracy can be
considered if it is apparent the variance parameter for threshold or accuracy cannot be estimated.
For the scaphoid fractures example, the results of the simulation indicate that using a univariate ﬁxed eﬀect
model (including the equivalent ﬁxed accuracy threshold and symmetric ﬁxed accuracy threshold models) was
valid because there was no heterogeneity in the speciﬁcities (all six studies reported 100% speciﬁcity) and very
limited heterogeneity in the sensitivities (ﬁve of the studies reported 100% sensitivity). Even for the ﬁxed eﬀect
models, computation of the positive likelihood ratio and DOR were problematic because of the perfect speciﬁcity.
5 Discussion
In this study we simulated meta-analyses under a number of scenarios and evaluated hierarchical models for meta-
analysis of diagnostic accuracy studies. Our ﬁndings indicate that simplifying hierarchical models is valid when
there are few studies or sparse data. Our recommendations for selecting alternative models when bivariate or
HSROC models fail to converge or converge but give unreliable estimates, are outlined in Box 1. If estimation of
an average operating point (summary sensitivity and speciﬁcity) is of interest instead of a SROC curve, we
recommend a univariate logistic regression approach with or without random eﬀects depending on the extent
to which sensitivity and/or speciﬁcity vary between studies. These methods are an appropriate alternative for
obtaining independent summaries of sensitivity and speciﬁcity with CIs. However, joint inferences cannot be made
about sensitivity and speciﬁcity through conﬁdence and prediction regions around the average operating point.
These regions account for correlation between sensitivity and speciﬁcity, and are useful for illustrating uncertainty
around the average operating point and the extent of heterogeneity. If interest lies in the estimation of a SROC
curve, the symmetric HSROC model or its ﬁxed eﬀect equivalent should be considered instead. The symmetric
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HSROC model is equivalent to ﬁtting a bivariate model with an exchangeable covariance structure, where the
variance of the random eﬀects for the logit sensitivities is assumed to be the same as that of the logit speciﬁcities. In
extreme situations with no heterogeneity and sparse data, such as the scaphoid fractures example, even the
simplest models may fail to produce usable summary estimates.
Given the poor performance of simpler models like the ﬁxed accuracy and ﬁxed threshold models in the
simulation, we urge meta-analysts to carefully explore their data and visually inspect forest plots and SROC
plots before undertaking meta-analyses. Such preliminary analyses will provide an indication of the degree of
heterogeneity and the pattern of scatter of the study points in ROC space. These analyses and the output from
unstable or failed models should inform the approach for simplifying hierarchical models as shown by the
appendicitis example. Although more complex and seldom used in practice, a Bayesian approach is an
alternative to the maximum likelihood approach. In an empirical evaluation, both approaches were found to
be similar although Bayesian methods suggested greater uncertainty (wide credible intervals) around the point
estimates.6
A normal distribution is typically assumed for the random eﬀects in hierarchical meta-analytic models;
violation of this assumption may contribute to non-convergence. Heavy tailed distributions such as t or
Cauchy distributions may be used instead of a normal distribution,2,11 but random eﬀects are restricted to be
normally distributed in SAS NLMIXED and Stata. A Bayesian approach allows alternative distributions though a
normal distribution is often assumed in practice.21 As the models are often ﬁtted using a maximum likelihood
approach, our intention was to oﬀer solutions within the hierarchical framework recommended for meta-analysis,
using one of the software packages that have made meta-analysis of test accuracy studies more accessible to meta-
analysts. A composite likelihood approach (implemented in R using the glmmML package) that oﬀers some
robustness to model misspeciﬁcations was recently proposed.28 Results from the simulation study where the
composite likelihood method and the bivariate generalized mixed model were applied to data generated from a
Box 1. Recommendations for selecting alternative models when bivariate or HSROC models fail.a
Plot the data
Visual inspection of forest plots and SROC plots may help to identify whether heterogeneity exists.
For example, one may observe complete or near complete lack of variability between estimates of sensitivity
and/or specificity, indicating no heterogeneity in one or both parameters (sensitivity and/or specificity equal
to 100%), or conversely wide variability in observed estimates (e.g. non-overlapping confidence intervals)
indicating large heterogeneity.
Analyses
Select a simpler hierarchical fixed effect or random effects model based on inference of interest (summary
points or SROC curve), observation from the data plot, and previous output from the failed bivariate or
HSROC model
Note: when prevalence is very low and the number of studies is very small, there is potential for bias and the
results of the meta-analysis should be interpreted with caution.
Focus of inference
Heterogeneity
Summary point (summary
sensitivity and specificity) SROC curve
Variability in sensitivity and/or
specificity between studies
observed on the plot
Univariate random effects
logistic regression models
Symmetric HSROC model
Minimal or no variability in
sensitivity and/or specificity
between studies observed on
the plot
Univariate fixed effect logistic
regression modelsb
Symmetric fixed accuracy and
threshold model
A symmetric SROC curve can be described using the diagnostic odds ratio (exponent of the value of the
accuracy parameter).
Section 4.1.3 contains suggestions for facilitating convergence of hierarchical models.
aBivariate or HSROC models either failed to converge or converged (i.e. met the convergence criterion) but gave unreliable estimates (e.g. with no
standard errors, or dependent on starting values).
bThe symmetric fixed accuracy threshold model is equivalent to simultaneously fitting two univariate fixed effect logistic regression models for
sensitivity and specificity.
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bivariate t distribution suggested the methods were insensitive to the heavy tailed distribution under the logit link
function. We used only the logit link in our models.
Our simulations and application to motivating examples support and extend empirical evidence suggesting that
univariate methods generate summary results similar to those derived using full hierarchical methods.4,6,29 Our
ﬁndings also agree with a recent simulation study evaluating the performance of the bivariate model.30 However,
our study is more comprehensive including application to real motivating examples, investigation of a broad array
of possible models, suggestions for improving model convergence and guidance on how to select an appropriate
model. Furthermore, we do not prescribe a limit on the number of studies required to ﬁt a hierarchical model,
rather the merit of applying a particular model should be carefully assessed as we have illustrated with our
examples.
Our study has some limitations. First, we were not able to fully explore the eﬀect of heterogeneity or varying the
threshold.We addressed factors we considered vital, and varied the sample size of studies in ameta-analysis to reﬂect
reality. According to Begg,31 the statistical properties of hierarchical models are likely to be most vulnerable when
the number of studies is small, and also when sample sizes are highly variable. Second, analyses of the simulated
datasets were conducted only in SAS and convergence rates may diﬀer between software packages because of
diﬀerences in obtaining starting values and model ﬁtting options. Nonetheless, SAS is the software most often
used to ﬁt HSROC models in frequentist analyses and we were able to explore several options for improving
convergence. Third, when comparing models, we did not limit analyses to datasets that converged across all
models. Non-convergence occurred more frequently in challenging datasets where poor model performance (bias,
MSE and coverage) can be expected. Therefore, more complex methods with poor convergence rates may be biased
or give imprecise estimates. The performance of simpler models with better convergence rates should also be aﬀected
but if the models give unbiased and precise estimates, then simpler models are robust and applicable in such
situations.
In summary, random eﬀects logistic models should be the default approach for test accuracy meta-analyses. We
recommend UREMs for sensitivity and speciﬁcity if a bivariate model fails, or a symmetric HSROC model if
estimation of a SROC curve is required and the HSROC model fails. If homogeneity can be assumed, the two
models can be further simpliﬁed to their ﬁxed eﬀect equivalent. However, when prevalence is very low and the
number of studies is very small, the results of any meta-analysis should be interpreted with caution.
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